RAD 202 receives approval to start Phase 1 therapeutic trial

By 8 hours ago0 view

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

House vote imminent on Trump-backed bill to avoid government shutdown

Completion of Tranche 1 of the Placement

Cyprium Metals Limited (ASX: CYM, OTC: CYPMF) (Cyprium or the Company) is pleased to announce ...

20Dec2024

Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation

Westgold Resources (ASX:WGX,TSX:WGX,OTCQX:WGXRF) has completed a scoping study that evaluates an expansion of its Fortnum ...

Enter Your Information Below To Receive Trading Ideas and Latest News

Your name

Your email

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

RAD 202 receives approval to start Phase 1 therapeutic trial

House vote imminent on Trump-backed bill to avoid government shutdown

Malls are using new restaurants to draw consumers as shopping centers reinvent themselves

Popular News

House vote imminent on Trump-backed bill to avoid government shutdown

Malls are using new restaurants to draw consumers as shopping centers reinvent themselves

You may also like

Completion of Tranche 1 of the Placement

Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation

Popular News